Milli-Mark Anti-Alzheimer Precursor P

Analysis Note

ControlB35 cells

Application

Anti-Alzheimer Precursor Protein A4 (N-terminus)-FITC Antibody, clone 22C11 detects level of Alzheimer Precursor Protein A4 (N-terminus) & has been published & validated for use in FC.

Research Sub CategoryNeurodegenerative Diseases

Research CategoryNeuroscience

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Deposits of amyloid protein in senile plaques near nerve processes are found in the brains of aged humand and cases of Alzheimer′s Disease. The principle component of this extracellular amyloid is beta A4, a 4 kDa peptide derived from a larger amyloid precursor protein (APP), which is widely expressed in the brain and body. The creation, transport and function of these proteins is currently an active area of research.

Immunogen

Purified recombinant Alzheimer precursor A4 (pre A4695) fusion protein.

Legal Information

MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany

Physical form

Protein A purified

Purified mouse monoclonal IgG1 conjugated to FITC in PBS with 0.1% sodium azide and 15 mg/mL BSA.

Quality

Evaluated by flow cytometry using B35 cells

Specificity

Antibody recognizes Alzheimer Precursor Protein

Storage and Stability

Maintain refrigerated at 2-8°C protected from light for up to 6 months from date of receipt.

Target description

110/120/130 kDa Calculated